Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Cell Cycle (Georgetown, Tex.)
|
November 19, 2019
Circ_0000003 promotes the proliferation and metastasis of non-small cell lung cancer cells via miR-338-3p/insulin receptor substrate 2
Shaobin Li, Xiaoge Niu, Hui Li, et al.
Frontiers in Pharmacology
|
October 15, 2025
Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study
Lin Tao, Xiaoling Zhang, Xiaoge Niu, et al.
Cancer Science
|
November 2, 2021
CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancer
Xiaoge Niu, Wei Wang, Taizhen Liang, et al.
Breast Cancer (Tokyo, Japan)
|
June 20, 2012
Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo
Xiaoge Niu, Shaobin Li, Fang Wei, et al.
Inorganic Chemistry
|
August 26, 2021
High Proton Conduction in Two Highly Water-Stable Lanthanide Coordination Polymers from a Triazole Multicarboxylate Ligand
Xiaoge Niu, Yihong Yu, Chenyu Mu, et al.
International Journal of Nephrology
|
April 16, 2025
Lack of Association Between Intraoperative Hypotension and Postoperative Acute Kidney Injury in Patients Undergoing Pancreaticoduodenectomy: A Retrospective Cohort Study
Yue Gu, Wenwen Zhang, Jing Zhou, et al.
ACS Infectious Diseases
|
June 1, 2026
Efavirenz Mitigates Dyslipidemia and Attenuates Ulcerative Colitis through Gut Microbiota Modulation
Wei Wang, Xiaoge Niu, Shasha Li, et al.
Diabetes Research and Clinical Practice
|
February 10, 2025
Sleep duration, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A prospective cohort study
Xiaoge Niu, Hongwei Liu, Yanxi Wang, et al.
Journal of Medicinal Chemistry
|
July 16, 2020
Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction as Potential Anticancer Agents
Binbin Cheng, Yichang Ren, Xiaoge Niu, et al.
Journal of Medicinal Chemistry
|
December 2, 2020
Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment
Binbin Cheng, Wei Wang, Xiaoge Niu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Cell Cycle (Georgetown, Tex.)
|
November 19, 2019
Circ_0000003 promotes the proliferation and metastasis of non-small cell lung cancer cells via miR-338-3p/insulin receptor substrate 2
Shaobin Li, Xiaoge Niu, Hui Li, et al.
Frontiers in Pharmacology
|
October 15, 2025
Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study
Lin Tao, Xiaoling Zhang, Xiaoge Niu, et al.
Cancer Science
|
November 2, 2021
CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancer
Xiaoge Niu, Wei Wang, Taizhen Liang, et al.
Breast Cancer (Tokyo, Japan)
|
June 20, 2012
Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo
Xiaoge Niu, Shaobin Li, Fang Wei, et al.
Inorganic Chemistry
|
August 26, 2021
High Proton Conduction in Two Highly Water-Stable Lanthanide Coordination Polymers from a Triazole Multicarboxylate Ligand
Xiaoge Niu, Yihong Yu, Chenyu Mu, et al.
International Journal of Nephrology
|
April 16, 2025
Lack of Association Between Intraoperative Hypotension and Postoperative Acute Kidney Injury in Patients Undergoing Pancreaticoduodenectomy: A Retrospective Cohort Study
Yue Gu, Wenwen Zhang, Jing Zhou, et al.
ACS Infectious Diseases
|
June 1, 2026
Efavirenz Mitigates Dyslipidemia and Attenuates Ulcerative Colitis through Gut Microbiota Modulation
Wei Wang, Xiaoge Niu, Shasha Li, et al.
Diabetes Research and Clinical Practice
|
February 10, 2025
Sleep duration, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A prospective cohort study
Xiaoge Niu, Hongwei Liu, Yanxi Wang, et al.
Journal of Medicinal Chemistry
|
July 16, 2020
Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction as Potential Anticancer Agents
Binbin Cheng, Yichang Ren, Xiaoge Niu, et al.
Journal of Medicinal Chemistry
|
December 2, 2020
Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment
Binbin Cheng, Wei Wang, Xiaoge Niu, et al.
Page
of 2